Relapsed Childhood Lymphoblastic Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed Childhood Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL (NCT05215405) | Kathleen Ludwig |
Track Relapsed Childhood Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.